Mete Şaylan

69.1k total citations
30 papers, 254 citations indexed

About

Mete Şaylan is a scholar working on Psychiatry and Mental health, Clinical Psychology and Economics and Econometrics. According to data from OpenAlex, Mete Şaylan has authored 30 papers receiving a total of 254 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Psychiatry and Mental health, 6 papers in Clinical Psychology and 6 papers in Economics and Econometrics. Recurrent topics in Mete Şaylan's work include Schizophrenia research and treatment (7 papers), Electroconvulsive Therapy Studies (5 papers) and Mental Health Treatment and Access (4 papers). Mete Şaylan is often cited by papers focused on Schizophrenia research and treatment (7 papers), Electroconvulsive Therapy Studies (5 papers) and Mental Health Treatment and Access (4 papers). Mete Şaylan collaborates with scholars based in Türkiye, United States and Switzerland. Mete Şaylan's co-authors include Kaan Kora, Claire B Irving, Alp Üçok, Kenneth V. White, David Goldman, Olcay Yazıcı, Georg Winterer, Richard Coppola, Mary-Anne Enoch and Emre Kiziltan and has published in prestigious journals such as SHILAP Revista de lepidopterología, Cochrane Database of Systematic Reviews and Journal of Affective Disorders.

In The Last Decade

Mete Şaylan

27 papers receiving 239 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mete Şaylan Türkiye 9 123 82 46 21 19 30 254
Kelli Lehto Estonia 10 67 0.5× 54 0.7× 31 0.7× 29 1.4× 15 0.8× 27 274
Igor Filipčić Croatia 10 121 1.0× 58 0.7× 63 1.4× 12 0.6× 18 0.9× 25 295
Ali Karayağmurlu Türkiye 7 83 0.7× 168 2.0× 41 0.9× 16 0.8× 8 0.4× 41 290
C. Alan Anderson United States 8 101 0.8× 61 0.7× 32 0.7× 33 1.6× 7 0.4× 14 250
Anastasiya Nestsiarovich United States 10 108 0.9× 62 0.8× 18 0.4× 30 1.4× 5 0.3× 19 274
Tyra Lagerberg United Kingdom 11 92 0.7× 80 1.0× 21 0.5× 61 2.9× 35 1.8× 32 299
Myrsini Gianatsi United Kingdom 5 177 1.4× 93 1.1× 16 0.3× 8 0.4× 9 0.5× 8 263
Sanobar Golshani Iran 10 52 0.4× 95 1.2× 39 0.8× 22 1.0× 6 0.3× 25 255
C Lançon France 9 204 1.7× 121 1.5× 21 0.5× 29 1.4× 7 0.4× 25 308
Beth J. Singer United States 8 177 1.4× 72 0.9× 22 0.5× 13 0.6× 7 0.4× 26 304

Countries citing papers authored by Mete Şaylan

Since Specialization
Citations

This map shows the geographic impact of Mete Şaylan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mete Şaylan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mete Şaylan more than expected).

Fields of papers citing papers by Mete Şaylan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mete Şaylan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mete Şaylan. The network helps show where Mete Şaylan may publish in the future.

Co-authorship network of co-authors of Mete Şaylan

This figure shows the co-authorship network connecting the top 25 collaborators of Mete Şaylan. A scholar is included among the top collaborators of Mete Şaylan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mete Şaylan. Mete Şaylan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Şaylan, Mete, et al.. (2020). PIN53 Cost of Productivity Loss of Common Cold and FLU in Turkey. Value in Health. 23. S553–S553. 1 indexed citations
2.
Şaylan, Mete, et al.. (2016). Impact of Health Policy Changes on Trends in the Pharmaceutical Market in Turkey. Value in Health Regional Issues. 10. 48–52. 8 indexed citations
3.
Şaylan, Mete, et al.. (2015). Inequity in Access to Alzheimer Disease Indicated Treatment Across Different Geographic Areas of Turkey. Value in Health. 18(7). A413–A414. 1 indexed citations
4.
Aksu, Kenan, Ahmet Gül, Yaşar Karaaslan, et al.. (2015). Cost of Familial Mediterranean Fever (Fmf) Disease In Turkey. Value in Health. 18(7). A666–A666. 3 indexed citations
5.
Tatar, Mehtap, et al.. (2014). Cost-Effectiveness of Omalizumab in Chronic Idiopathic Urticaria Refractory to H1-Antihistamines in Turkey. Value in Health. 17(7). A604–A604. 3 indexed citations
6.
Tatar, Mehtap, Ayşegül Şentürk, Cem Mat, et al.. (2014). Cost-Analysis of Chronic Idiopathic Urticaria Disease. Value in Health. 17(7). A606–A606. 1 indexed citations
7.
8.
Treuer, Tamás, Ferenc Martényi, Mete Şaylan, & Yulia Dyachkova. (2010). Factors associated with achieving minimally symptomatic status by patients with schizophrenia: results from the 3-year intercontinental schizophrenia outpatients health outcomes study. International Journal of Clinical Practice. 64(6). 697–706. 5 indexed citations
9.
10.
Şaylan, Mete, Alp Üçok, Şükrü Uğuz, Tamás Treuer, & Aytekin Sır. (2009). Analysis of social class by LCA in patients with schizophrenia: change in psychopathology after 12-month of treatment -. Klinik Psikofarmakoloji Bülteni-Bulletin of Clinical Psychopharmacology. 19(1). 29–38. 3 indexed citations
11.
Kora, Kaan, Mete Şaylan, Cengiz Akkaya, et al.. (2008). Predictive Factors for Time to Remission and Recurrence in Patients Treated for Acute Mania. The Primary Care Companion to The Journal of Clinical Psychiatry. 10(2). 114–119. 23 indexed citations
12.
Dossenbach, Martín, et al.. (2007). Olanzapine Versus Chlorpromazine in the Treatment of Schizophrenia. Journal of Clinical Psychopharmacology. 27(4). 329–337. 7 indexed citations
13.
14.
Şaylan, Mete, et al.. (2006). Efficacy of tadalafil in Egyptian and Turkish men with erectile dysfunction. International Journal of Clinical Practice. 60(7). 812–819. 10 indexed citations
15.
Şaylan, Mete & Raşit Tükel. (2005). Bleeding attributed to the use of paroxetine. SHILAP Revista de lepidopterología. 15(2). 79–83. 1 indexed citations
16.
Şaylan, Mete, et al.. (2004). The Intercontinental Schizophrenia Outpatient Health Outcomes (IC-SOHO) Study: Baseline Clinical and Functional Characteristics and Antipsychotic Use Patterns in Turkey*. Klinik Psikofarmakoloji Bülteni-Bulletin of Clinical Psychopharmacology. 14(3). 132–142. 5 indexed citations
17.
Bılgıç, Başar, et al.. (2004). Obsessive–Compulsive Disorder Secondary to Bilateral Frontal Damage Due to a Closed Head Injury. Cognitive and Behavioral Neurology. 17(2). 118–120. 10 indexed citations
18.
Winterer, Georg, Mary-Anne Enoch, Kenneth V. White, et al.. (2003). EEG phenotype in alcoholism: increased coherence in the depressive subtype. Acta Psychiatrica Scandinavica. 108(1). 51–60. 50 indexed citations
19.
Yazıcı, Olcay, Kaan Kora, Alp Üçok, et al.. (2002). Unipolar mania: a distinct disorder?. Journal of Affective Disorders. 71(1-3). 97–103. 39 indexed citations
20.
Üçok, Alp, et al.. (1998). Şizofreni hastalarında obsesif kompulsif belirtilerin ve bozukluğun sıklığı. 6(2). 107–110. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kelli Lehto Breakdown of academic impact, for papers by Igor Filipčić Breakdown of academic impact, for papers by Ali Karayağmurlu Breakdown of academic impact, for papers by C. Alan Anderson Breakdown of academic impact, for papers by Anastasiya Nestsiarovich Breakdown of academic impact, for papers by Tyra Lagerberg Breakdown of academic impact, for papers by Myrsini Gianatsi Breakdown of academic impact, for papers by Sanobar Golshani Breakdown of academic impact, for papers by C Lançon Breakdown of academic impact, for papers by Beth J. Singer
Rankless by CCL
2026